IRIS
LANZILLOTTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.722
NA - Nord America 1.332
EU - Europa 1.330
SA - Sud America 432
AF - Africa 21
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.849
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.259
SG - Singapore 655
IT - Italia 614
CN - Cina 595
BR - Brasile 350
SE - Svezia 249
HK - Hong Kong 218
DE - Germania 111
VN - Vietnam 97
RU - Federazione Russa 89
GB - Regno Unito 61
FI - Finlandia 49
IN - India 42
CA - Canada 36
AR - Argentina 34
PL - Polonia 31
MX - Messico 27
NL - Olanda 27
JP - Giappone 24
TR - Turchia 21
ES - Italia 20
AT - Austria 17
FR - Francia 14
ZA - Sudafrica 14
EC - Ecuador 12
IE - Irlanda 12
PE - Perù 12
ID - Indonesia 11
CO - Colombia 9
IQ - Iraq 9
UA - Ucraina 9
IL - Israele 8
NZ - Nuova Zelanda 7
BD - Bangladesh 6
PK - Pakistan 6
LT - Lituania 5
PH - Filippine 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CL - Cile 4
IR - Iran 4
PY - Paraguay 4
TN - Tunisia 4
UZ - Uzbekistan 4
VE - Venezuela 4
CH - Svizzera 3
LV - Lettonia 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BE - Belgio 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
JO - Giordania 2
PA - Panama 2
AM - Armenia 1
BH - Bahrain 1
DM - Dominica 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
NI - Nicaragua 1
NP - Nepal 1
SA - Arabia Saudita 1
SV - El Salvador 1
TW - Taiwan 1
Totale 4.849
Salva come PNG Salva come JPEG
Città #
Singapore 315
Dallas 296
Hong Kong 215
Shanghai 156
Ashburn 149
Beijing 116
Milan 95
Hefei 85
New York 77
Lawrence 69
Princeton 69
Los Angeles 55
Rome 48
Moscow 42
Boardman 40
Munich 37
Helsinki 35
Ho Chi Minh City 35
São Paulo 32
Warsaw 26
Nuremberg 25
Denver 23
London 22
Hanoi 21
Tokyo 21
Poplar 19
Cagliari 17
Orem 17
Pune 15
Seattle 15
Montreal 14
Turin 13
Ankara 12
Dublin 12
Florence 12
Rio de Janeiro 12
Boston 11
Brooklyn 11
Santa Clara 11
Bari 10
Bologna 10
Guangzhou 10
Mexico City 10
Phoenix 10
Rovigo 10
Atlanta 9
Belo Horizonte 9
Bergamo 9
Chennai 9
Frankfurt am Main 9
Galliate 9
Pescara 9
Stockholm 9
Toronto 9
Amsterdam 8
Johannesburg 8
Naples 8
Turku 8
Vaprio d'Adda 8
Verona 8
Breda 7
Falkenstein 7
Haiphong 7
Jakarta 7
Mugnano di Napoli 7
Querétaro 7
Brasília 6
Cesano Boscone 6
Jiaxing 6
Monza 6
Mumbai 6
Secaucus 6
Vienna 6
Auckland 5
Baghdad 5
Campo Grande 5
Caxias do Sul 5
Chicago 5
Houston 5
Kyiv 5
Lappeenranta 5
Mezzolombardo 5
Mira 5
New Delhi 5
Perugia 5
Quito 5
Salvador 5
San Francisco 5
The Dalles 5
Vittoria 5
Alessandria 4
Borås 4
Bắc Giang 4
Campinas 4
Curitiba 4
Genoa 4
Istanbul 4
Mantova 4
Minerbio 4
Miraflores District 4
Totale 2.693
Salva come PNG Salva come JPEG
Nome #
PACHIMENINGITE IPERTROFICA IGG4-CORRELATA: DIAGNOSI E RISPOSTA TERAPEUTICA 322
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 133
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 115
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 109
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 102
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 95
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 95
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 93
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 89
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 86
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 80
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 79
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 79
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 78
Advances in the diagnosis and management of IgG4 related disease. 75
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 72
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 71
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 70
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 69
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 69
CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES 69
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 67
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 66
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 65
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 65
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 62
CLINICAL PHENOTYPES OF IGG4-RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL, IMMUNOLOGICAL AND PROGNOSTIC FEATURES 62
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 60
A unique case of IgG4-related pachymeningitis treated with intrathecal rituximab 60
CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE 60
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 59
Urgent manifestations of immunoglobulin G4-related disease 59
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 59
Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. 58
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 57
Igg4-related disease of the oral cavity. Case series from a large single-center cohort of italian patients 56
IgG4-RELATED DISEASE PRESENTATION REQUIRES ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES 53
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE 52
INCREASE OF CIRCULATING MEMORY B CELLS AFTER GLUCOCORTICOID-INDUCED REMISSION PREDICTS IGG4-RELATED DISEASE RELAPSE 52
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 51
EFFECTS OF GLUCOCORTICOIDS AND METHOTREXATE-BASED THERAPEUTIC REGIMENS ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 51
An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index 51
Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort 49
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis 49
INFLAMMATORY ACTIVITY OF IgG4-RELATED DISEASE LESIONS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY CORRELATES WITH CIRCULATING PLASMABLASTS LEVELS 49
IDENTIFICAZIONE DI UNA SOTTOPOPOLAZIONE CD8- DI LINFOCITI CD4 CITOTOSSICI ESPANSA NEI PAZIENTI CON MALATTIA IGG4-CORRELATA E RESPONSIVA ALLA TERAPIA CON GLUCOCORTICOIDI 49
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 49
Association of IgG4-related disease and systemic rheumatic disorders 48
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 48
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 48
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease. 48
MALATTIA IGG4-CORRELATA: ESPERIENZA QUINQUENNALE MONOCENTRICA SU UNA CORTE ITALIANA DI 150 PAZIENTI (2013 - 2018) 48
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease 46
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 45
EFFETTI DEL PREDNISONE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI CON MALATTIA IgG4-CORRELATA 44
Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse 43
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 43
CIRCULATING PLASMABLASTS LEVELS REFLECT INFLAMMATORY ACTIVITY IN IGG4-RELATED DISEASE LESIONS AS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY 42
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 41
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease 40
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 40
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 40
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. 38
Disentangling inflammatory drivers of fibrosis in IgG4-related disease 37
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circula-ting plasmablasts in IgG4-related type 1 au-toimmune pancreatitis and other organs 37
IGG4-RELATED DISEASE IN ITALY: RESULTS FROM A MONOCENTRIC COHORT OF 150 PATIENTS (2013–2018) 37
EFFICACY AND SAFETY OF RITUXIMAB FOR INDUCTION OF REMISSION AND MAINTENANCE OF IGG4-RELATED DISEASE: EXPERIENCE FROM AN ITALIAN NATIONAL REFERRAL CENTRE 37
FENOTIPI CLINICI DELLA MALATTIA IGG4 CORRELATA: ANALISI CROSS-SECTIONAL DI UNA CORTE INTERNAZIONALE 37
Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis 36
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 36
Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease 36
Roles of Plasmablasts and B Cells in IgG4-Related Disease: Implications for Therapy and Early Treatment Outcomes 35
Methotrexate as induction of remission the-rapy for IgG4-Related type 1 Autoimmune Pancreatitis 34
HLA-DRB1∗16 and -DQB1∗05 alleles are strongly associated with autoimmune pancreatitis in a cohort of hundred patients 33
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 32
EFFETTI DELLA TERAPIA CON PREDNISONE E METHOTREXATE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI AFFETTI DA MALATTIA-IgG4 CORRELATA 32
DECONSTRUCTING LA MALATTIA DA IGG4 CON INTERESSAMENTO DELLE STRUTTURE MEDIANE: CONFRONTO CON I COMUNI “MIMICKERS” 32
Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease 31
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. 31
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 31
Immunology of IgG4-related disease 30
Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis 28
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment 28
Serum IgG4 level predicts COVID-19 related mortality 27
Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply 27
EFFICACIA E SICUREZZA DELLA SOMMINISTRAZIONE INTRATECALE DI RITUXIMAB PER IgG4-RELATED PACHIMENINGITE IPERTROFICA REFRATTARIA 26
Totale 4.972
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.045
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 8 0 1 1 1 2 1
2021/2022156 0 0 46 12 2 10 7 9 21 15 18 16
2022/2023546 170 93 42 6 12 54 53 40 33 5 12 26
2023/2024593 26 39 69 46 38 88 22 69 6 24 61 105
2024/20251.474 139 57 51 50 72 105 243 172 252 89 96 148
2025/20262.169 332 372 361 552 429 123 0 0 0 0 0 0
Totale 4.972